GLAD

Business Context and Reporting Period

Company: Gladstone Capital Corporation (GLAD)
Filing Type: Form 10-K (Annual Report)
Period Ended: September 30, 2012
Business Overview: Gladstone Capital is a closed-end, non-diversified management investment company operating as a Business Development Company (BDC) and a Regulated Investment Company (RIC). Its strategy focuses on investing in debt and equity securities of established private U.S. businesses to generate current income and long-term capital appreciation. The portfolio consists of senior debt, senior subordinated debt, junior subordinated debt, and preferred/common equity.

Key Financial Metrics

Material Changes vs. Prior Period

• Portfolio Contraction: The portfolio fair value decreased by approximately $29 million (9.6%) year-over-year, driven by $60.2 million in unscheduled principal repayments (including 10 early payoffs) and fewer new investments compared to 2011.
• Realized Losses: Net realized losses increased significantly to $12.8 million in 2012 from $1.3 million in 2011. Major contributors included the sale of Newhall Holdings ($7.4 million loss), BERTL ($1.8 million loss), and U.S. Healthcare Communications ($3.2 million loss).
• Unrealized Depreciation: Net unrealized depreciation on investments was $11.2 million in 2012, a significant improvement from the $38.8 million depreciation recorded in 2011. This improvement was partially due to the reversal of prior depreciation upon the realization of losses on specific assets.
• Liquidity and Capital: The company issued 1.5 million shares of 7.125% Series 2016 Term Preferred Stock in November 2011, raising $38.5 million. Borrowings under the Credit Facility were reduced from $99.4 million to $58.8 million.
• Non-Accrual Status: The number of portfolio companies on non-accrual status decreased from eight in 2011 to six in 2012. However, the aggregate debt cost basis on non-accrual increased to $61.1 million (17.3% of total debt cost basis) from $41.1 million (11.0%) in the prior year.

Guidance, Outlook, and Risks

• Management Commentary: Management remains cautious regarding the long-term economic recovery. They noted increased competitive pressure in the BDC marketplace, resulting in lower yields for riskier investments. The company plans to focus on building a pipeline of investments that meet its objectives and provide appropriate risk-adjusted returns.
• Strategic Revisions: The Board approved limited revisions to investment objectives and strategies effective January 1, 2013. No changes to the current portfolio are required.
• Key Risks:
  • Concentration Risk: The five largest investments represented 33.5% of the total portfolio at fair value. Significant exposure exists in Electronics (15.4%), Healthcare/Education (12.0%), and Mining/Steel (11.5%).
  • Liquidity Constraints: The company's ability to raise equity capital is constrained because its common stock has consistently traded below NAV. Issuing stock below NAV requires stockholder approval.
  • Credit Facility Covenants: The company must maintain a minimum net worth of $227.1 million and an asset coverage ratio of at least 200%. Continued unrealized depreciation could threaten compliance with these covenants.
  • Valuation Uncertainty: A significant portion of the portfolio is valued using Level 3 inputs (unobservable data), introducing subjectivity to the reported fair values.

Investor Verification Checklist

• Non-Accrual Portfolio: Verify the specific financial status and recovery plans for the six portfolio companies on non-accrual status, which represent 17.3% of the debt cost basis.
• Realized Losses: Review the details of the $12.8 million in realized losses to understand the specific triggers (e.g., sales of distressed assets) and their impact on future cash flows.
• Fee Waivers: Confirm the status of voluntary fee waivers from the Adviser, which reduced the base management fee on syndicated loans and the incentive fee to ensure distributions were covered by net investment income.
• NAV Discount: Monitor the trading price of common stock relative to NAV ($8.98), as a persistent discount limits the company's ability to raise equity capital without dilution or stockholder approval.
• Covenant Compliance: Track the asset coverage ratio and minimum net worth requirements to ensure the company remains in compliance with its Credit Facility and Term Preferred Stock terms.